Immunitybio Stock Filter Stocks by Fundamentals
| IBRX Stock | USD 5.49 0.55 11.13% |
Immunitybio fundamentals help investors to digest information that contributes to Immunitybio's financial success or failures. It also enables traders to predict the movement of Immunitybio Stock. The fundamental analysis module provides a way to measure Immunitybio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immunitybio stock.
Immunitybio | Shares Owned by Insiders |
Immunitybio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Immunitybio from analyzing Immunitybio's financial statements. These drivers represent accounts that assess Immunitybio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Immunitybio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.5B | 5.1B | 2.4B | 2.0B | 2.6B | 3.6B | |
| Enterprise Value | 1.5B | 5.3B | 2.8B | 2.6B | 3.2B | 3.8B |
Immunitybio Institutional Holders
Institutional Holdings refers to the ownership stake in Immunitybio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Immunitybio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Immunitybio's value.| Shares | Rafferty Asset Management, Llc | 2023-12-31 | 739.8 K | Allen Holding Inc | 2023-12-31 | 687.6 K | Amvescap Plc. | 2023-12-31 | 641.4 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 599.7 K | Putnam Investments, Llc., A Franklin Templeton Company | 2023-12-31 | 534.2 K | Nuveen Asset Management, Llc | 2023-12-31 | 522.5 K | Bank Of New York Mellon Corp | 2023-12-31 | 482.4 K | Barclays Plc | 2023-12-31 | 479.5 K | Bsc Private Wealth Management, Llc | 2023-12-31 | 443.3 K | Vanguard Group Inc | 2023-12-31 | 13.3 M | Blackrock Inc | 2023-12-31 | 10.7 M |
Immunitybio Fundamentals
| Return On Asset | -0.52 | ||||
| Operating Margin | (607.93) % | ||||
| Current Valuation | 3.95 B | ||||
| Shares Outstanding | 677 M | ||||
| Shares Owned By Insiders | 79.61 % | ||||
| Shares Owned By Institutions | 8.80 % | ||||
| Number Of Shares Shorted | 54.77 M | ||||
| Price To Sales | 5,562 X | ||||
| Revenue | 622 K | ||||
| Gross Profit | 240 K | ||||
| EBITDA | (342.85 M) | ||||
| Net Income | (583.2 M) | ||||
| Cash And Equivalents | 82.94 M | ||||
| Cash Per Share | 0.21 X | ||||
| Total Debt | 883.68 M | ||||
| Current Ratio | 0.31 X | ||||
| Book Value Per Share | (0.88) X | ||||
| Cash Flow From Operations | (366.76 M) | ||||
| Short Ratio | 12.86 X | ||||
| Earnings Per Share | (1.15) X | ||||
| Price To Earnings To Growth | 3.69 X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 628 | ||||
| Beta | 0.039 | ||||
| Market Capitalization | 3.34 B | ||||
| Total Asset | 504.45 M | ||||
| Retained Earnings | (2.96 B) | ||||
| Working Capital | 235.8 M | ||||
| Net Asset | 504.45 M |
About Immunitybio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immunitybio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunitybio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunitybio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Immunitybio Investors Sentiment
The influence of Immunitybio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Immunitybio. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Immunitybio's public news can be used to forecast risks associated with an investment in Immunitybio. The trend in average sentiment can be used to explain how an investor holding Immunitybio can time the market purely based on public headlines and social activities around Immunitybio. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Immunitybio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Immunitybio's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Immunitybio's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Immunitybio.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunitybio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunitybio's short interest history, or implied volatility extrapolated from Immunitybio options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Immunitybio Piotroski F Score and Immunitybio Altman Z Score analysis. For more information on how to buy Immunitybio Stock please use our How to Invest in Immunitybio guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Immunitybio Stock analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Immunitybio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunitybio. If investors know Immunitybio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunitybio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share 0.001 | Quarterly Revenue Growth 0.904 | Return On Assets (0.52) |
The market value of Immunitybio is measured differently than its book value, which is the value of Immunitybio that is recorded on the company's balance sheet. Investors also form their own opinion of Immunitybio's value that differs from its market value or its book value, called intrinsic value, which is Immunitybio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunitybio's market value can be influenced by many factors that don't directly affect Immunitybio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunitybio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunitybio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunitybio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.